Health-Care Resource Use by Asthmatics in Croatia

REFERENCES

• Asthma Mortality and Hospitalization Among Children and Young Adults—United States, 1980–1993. From the Centers for Disease Control and Prevention. JAMA 1996; 275(20)1535–1537
   Google Scholar
• National Heart, Lung and Blood Institute–-WHO. Global Strategy for Asthma Management and Prevention. NIH Publication No. 95–3659. Bethesda, MD: National Institutes of Health; 1995
   Google Scholar
• Legorreta A.P., Liu X., Zaher C.A., Jatulis D.E. Variation in Managing Asthma: Experience at the Medical Group Level in California. Am. J. Manag. Care 2000; 6(4)445–453
   PubMed Web of Science ®Google Scholar
• Nestor A., Calhoun A.C., Dickson M., Kalik C.A. Cross-sectional Analysis of the Relationship Between National Guideline Recommended Asthma Drug Therapy and Emergency/Hospital Use Within a Managed Care Population. Ann. Allergy Asthma Immunol. 1998; 81(4)327–330
   PubMed Web of Science ®Google Scholar
• Stempel D.A., Durcannin-Robbins J.F., Hedblom E.C., Woolf R., Sturm L.L., Stempl A.B. Drug Utilization Evaluation Identifies Costs Associated with High Use of Beta-adrenergic Agonists. Ann. Allergy Asthma Immunol. 1996; 76(2)153–158
   Google Scholar
• National Asthma Education and Prevention Program. National Heart, Lung and Blood Institute Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. NIH Publication No. 97–4051. Bethesda, MD: National Institutes of Health; 1997
   Google Scholar
• Cerveri I., Zoia M.C., Bugiani M., Corsico A., Carosso A., Piccioni P., Casali L., De Marco R. Inadequate Antiasthma Drug Use in the North of Italy. Eur. Respir. J. 1997; 10(12)2761–2765
   PubMedGoogle Scholar
• Gourgoulianis K.I., Hamos B., Christou K., Rizopoulou D., Efthimiou A. Prescription of Medications by Primary Care Physicians in the Light of Asthma Guidelines. Respiration 1998; 65(1)18–20
   Google Scholar
• Lagerlov P., Veninga C.C., Muskova M., Hummers-Pradier E., Stalsby-Lundborg C., Andrew M., Haaijer-Ruskamp F.M. Asthma Management in Five European Countries: Doctors' Knowledge, Attitudes and Prescribing Behaviour. Drug Education Project (DEP) Group. Eur. Respir. J. 2000; 15(1)25–29
   Google Scholar
• Roghmann M.C., Sexton M. Adherence to Asthma Guidelines in General Practices. J. Asthma 1999; 36(4)381–387
   PubMed Web of Science ®Google Scholar
• Laumann J.M., Bjornson D.C. Treatment of Medicaid Patients with Asthma: Comparison with Treatment Guidelines Using Disease-based Drug Utilization Review Methodology. Ann. Pharmacother. 1998; 32(12)1290–1294
   PubMed Web of Science ®Google Scholar
• Picken H.A., Greenfield S., Teres D., Hirway P.S., Landis J.N. Effect of Local Standards on the Implementation of National Guidelines for Asthma: Primary Care Agreement with National Asthma Guidelines. J. Gen. Intern. Med. 1998; 13(10)659–663
   Google Scholar
• Jatulis D.E., Meng Y.Y., Elashoff R.M., Schocket A.L., Evans R.M., Hasan A.G., Legorreta A.P. Preventive Pharmacologic Therapy Among Asthmatics: Five Years After Publication of Guidelines. Ann. Allergy Asthma Immunol. 1998; 81(1)82–88
   PubMed Web of Science ®Google Scholar
• Ramage L., Lipworth B.J., Ingram C.G., Cree I.A., Dhillon D.P. Reduced Protection Against Exercise Induced Bronchoconstriction After Chronic Dosing with Salmeterol. Respir. Med. 1994; 88(5)363–368
   PubMed Web of Science ®Google Scholar
• Kemp J.P. Guidelines Update: Where Do the New Therapies Fit in the Management of Asthma? NHLBI and WHO Global Initiative for Asthma. Drugs 2000; 59(Suppl 1)23–28, discussion 43–45
   Google Scholar
• Villaran C., O'Neill S.J., Helbling A., van Noord J.A., Lee T.H., Chuchalin A.G., Langley S.J., Gunawardena K.A., Suskovic S., Laurenzi M. Montelukast Versus Salmeterol in Patients with Asthma and Exercise-Induced Bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J. Allergy Clin. Immunol. 1999; 104(3 Pt 1)547–553
   PubMedGoogle Scholar
• Laviolette M., Malmstrom K., Lu S., Chervinsky P., Pujet J.C., Peszek I., Zhang J., Reiss T.F. Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma. Montelukast/Beclomethasone Additivity Group. Am. J. Respir. Crit. Care Med. 1999; 160(6)1862–1868
   PubMed Web of Science ®Google Scholar
• Lofdahl C.G., Reiss T.F., Leff J.A., Israel E., Noonan M.J., Finn A.F., Seidenberg B.C., Capizzi T., Kundu S., Godard P. Randomised, Placebo Controlled Trial of Effect of a Leukotriene Receptor Antagonist, Montelukast, on Tapering Inhaled Corticosteroids in Asthmatic Patients. Br. Med. J. 1999; 319(7202)87–90
   PubMed Web of Science ®Google Scholar
• Drazen J.M., Boccuzzi S.J., Wogen J., Strub P., Jones C., Nelsen L., Santanello N. Adherence to Prescribed Treatment for Asthma [Poster B36]. Presented at: American Thoracic Society, Toronto, ON, 2000
   Google Scholar
• Price D., Ben-Joseph R., Zhang Q. Adherence to Asthma Medications in the United Kingdom [Poster B35]. Presented at: American Thoracic Society, Toronto, ON, 2000
   Google Scholar
• Cochrane M.G., Bala M.V., Downs K.E., Mauskopf J., Ben-Joseph R.H. Inhaled Corticosteroids for Asthma Therapy: Patient Compliance, Devices, and Inhalation Technique. Chest 2000; 117(2)542–550
   PubMed Web of Science ®Google Scholar